Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
249 questions in 68 reviews · Airways
current versionsNo studies 249 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care Quality of sleep Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Adaptive servo ventilation (ASV) vs bilevel ventilation Time to life‐saving cardiovascular intervention Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control Central AHI Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control Serious adverse events Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control Quality of sleep Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control Time to life‐saving cardiovascular intervention Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care Quality of life Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP) Central AHI Non‐invasive positive pressure ventilation for central sleep apnoea in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
14 days on/off antibiotic regimen vs 28 days on/off antibiotic regimen Exacerbation frequency · people with bronchiectasis Intermittent prophylactic antibiotics for bronchiectasis (2022) · Cochrane | no estimate extracted | NR | No studies |
14 days on/off antibiotic regimen vs 28 days on/off antibiotic regimen Frequency of hospital admissions for pulmonary exacerbations ‐ not measured · people with bronchiectasis Intermittent prophylactic antibiotics for bronchiectasis (2022) · Cochrane | no estimate extracted | NR | No studies |
14 days on/off antibiotic regimen vs 14 days on/off placebo regimen Frequency of hospital admissions for pulmonary exacerbations ‐ not measured · people with bronchiectasis Intermittent prophylactic antibiotics for bronchiectasis (2022) · Cochrane | no estimate extracted | NR | No studies |
Pulmonary rehabilitation vs usual care Adverse events · Adults with asthma Pulmonary rehabilitation versus usual care for adults with asthma (2022) · Cochrane | no estimate extracted | NR | No studies |
Nebulised magnesium sulfate + standard care vs placebo + standard care Proportion of people with serious adverse events · acute exacerbations of chronic obstructive pulmonary disease Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulfate vs standard care (ipratropium bromide) Proportion of people with serious adverse events · acute exacerbations of chronic obstructive pulmonary disease Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulfate vs standard care (ipratropium bromide) Change in oxygen saturation (SaO2) · acute exacerbations of chronic obstructive pulmonary disease Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulfate vs standard care (ipratropium bromide) Change in dyspnoea score · acute exacerbations of chronic obstructive pulmonary disease Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulfate vs standard care (ipratropium bromide) Lung function: FEV1 at 60 min · acute exacerbations of chronic obstructive pulmonary disease Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcome№ of participants(studies) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescent sand adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR HD Triple vs. MD Triple · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD Triple · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcome№ of participants(studies) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcome№ of participants(studies) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcome№ of participants(studies) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR MD‐ICS/LABA · Adolescents and adults with symptomatic asthma Interventions: HD‐ICS/LABA, MD‐TRIPLE, HD‐TRIPLE Comparator… Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcome№ of participants(studies) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and… (2022) · Cochrane | no estimate extracted | NR | No studies |
Medical or surgical intervention, or both, for gastro‐oesophageal reflux disease vs nil intervention, delayed intervention control, or placebo Healthcare utilisation ‐ not measured · treatment for asthma in adults and children with asthma and GORD Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and… (2021) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs placebo Outcomesa · adults and children with chronic asthma Macrolides versus placebo for chronic asthma (2021) · Cochrane | no estimate extracted | NR | No studies |
Anti‐IL13 or anti‐IL4 agents vs placebo Time off work or study · children and adults with asthma Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or… (2021) · Cochrane | no estimate extracted | NR | No studies |
Telerehabilitation vs centre‐based (outpatient) pulmonary rehabilitation Primary rehabilitation · Chronic respiratory disease Telerehabilitation for chronic respiratory disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Telerehabilitation vs no rehabilitation control Primary rehabilitation · Chronic respiratory disease Telerehabilitation for chronic respiratory disease (2021) · Cochrane | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) vs sham CPAP Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive… (2021) · Cochrane | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors Health‐related quality of life · erectile dysfunction in men with obstructive sleep apnoea Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive… (2021) · Cochrane | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) vs no CPAP Health‐related quality of life · erectile dysfunction in men with obstructive sleep apnoea Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive… (2021) · Cochrane | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) vs no CPAP Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive… (2021) · Cochrane | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) vs sham CPAP Serious adverse events · erectile dysfunction in men with obstructive sleep apnoea Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring plus usual care vs usual care Exacerbations · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring plus usual care vs usual care Mortality · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring vs usual care Exacerbations · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring vs usual care Quality of life · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring vs usual care Symptoms of dyspnoea · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring vs usual care Mortality · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Multi‐component interventions (with telehealth as a component of care) vs usual care Exacerbations · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Multi‐component interventions (with telehealth as a component of care) vs usual care Quality of life · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |